Skip to main content

Advertisement

Log in

Improving Medication Adherence in Migraine Treatment

  • Psychological and Behavioral Aspects of Headache and Pain (D Buse, Section Editor)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Medication adherence is integral to successful treatment of migraine and other headache. The existing literature examining medication adherence in migraine is small, and the methodologies used to assess adherence are limited. However, these studies broadly suggest poor adherence to both acute and preventive migraine medications, with studies using more objective monitoring reporting lower adherence rates. Methods for improving medication adherence are described, including organizational strategies, provider-monitoring and self-monitoring of adherence, regimen strategies, patient education, self-management skills training (e.g., stimulus control, behavioral contracts), and cognitive–behavioral therapy techniques. The article concludes by discussing the future of research regarding adherence to medications for migraine and other headaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Katic BJ, Krause SJ, Tepper SJ, Hu HX, Bigal ME. Adherence to acute migraine medication: what does it mean, why does it matter? Headache. 2010;50(1):117–29.

    Article  PubMed  Google Scholar 

  2. Reed ML, Fanning KM, Serrano D, Buse DC, Lipton RB. Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results. Headache. 2015;55(1):76–87.

  3. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343–9.

    Article  CAS  PubMed  Google Scholar 

  4. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48(8):1157–68.

    Article  PubMed  Google Scholar 

  5. Lipton RB, Fanning KM, Serrano D, Reed ML, Cady R, Buse DC. Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology. 2015;84(7):688–95. This large epidemiologic study provides evidence that patient perception of medication efficacy is associated with migraine chronification.

  6. Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78(17):1337–45.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78(17):1346–53.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Rains JC, Lipchik GL, Penzien DB. Behavioral facilitation of medical treatment for headache—part I: review of headache treatment compliance. Headache. 2006;46(9):1387–94.

    Article  PubMed  Google Scholar 

  9. Ramsey RR, Ryan JL, Hershey AD, Powers SW, Aylward BS, Hommel KA. Treatment adherence in patients with headache: a systematic review. Headache J Head Face Pain. 2014;54(5):795–816. This is a thorough review of the treatment adherence literature across patients with headache, which highlights the paucity of research on acute medication adherence, adherence with lifestyle recommendations, and adherence with children and adolescents.

    Article  Google Scholar 

  10. Nicholson RA, Smith TR. Likelihood of patients adhering to acute medication during migraine attacks. Submitted for presentation at the annual scientific meeting of the American Headache Society, Washington, DC.

  11. Nicholson RA, Chibnall JT, Ng-Mak D, Banks JW, Smith TR. Why wait? Reasons that patients delay taking a triptan during individual migraine attacks. Headache. 2011;51(S1):S6–7.

    Google Scholar 

  12. Sattler EL, Lee JS, Perri 3rd M. Medication (re)fill adherence measures derived from pharmacy claims data in older Americans: a review of the literature. Drugs Aging. 2013;30(6):383–99.

    Article  PubMed  Google Scholar 

  13. Nau DP. Proportion of days covered (PDC) as a preferred method of measuring medication adherence http://www.pqaalliance.org/images/uploads/files/PQA%20PDC%20vs%20%20MPR.pdf: Pharmacy Quality Alliance; [cited 2014 December 4].

  14. Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB. Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia. 2014;27:2014.

    Google Scholar 

  15. Hepp Z, Bloudek LM, Varon SF. Systematic review of migraine prophylaxis adherence and persistence. J Manag Care Pharm. 2014;20(1):22–33.

    PubMed  Google Scholar 

  16. Mulleners WM, Whitmarsh TE, Steiner TJ. Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better. Cephalalgia. 1998;18(1):52–6.

    Article  CAS  PubMed  Google Scholar 

  17. Steiner TJ, Catarci T, Hering R, Whitmarsh T, Couturier EG. If migraine prophylaxis does not work, think about compliance. Cephalalgia. 1994;14(6):463–4.

    Article  CAS  PubMed  Google Scholar 

  18. Matchar D, Harpole L, Samsa G, Jurgelski A, Lipton R, Silberstein S, et al. The headache management trial: a randomized study of coordinated care. Headache. 2008;48(9):1294–310.

    Article  PubMed  Google Scholar 

  19. Oberje EJ, de Kinderen RJ, Evers SM, van Woerkum CM, de Bruin M. Cost effectiveness of medication adherence-enhancing interventions: a systematic review of trial-based economic evaluations. Pharmacoeconomics. 2013;31(12):1155–68.

    Article  PubMed  Google Scholar 

  20. Messali AJ, Yang M, Gillard P, Tsai K, Tepper SJ, Bloudek LM, et al. Treatment persistence and switching in triptan users: a systematic literature review. Headache. 2014;54(7):1120–30.

    Article  PubMed  Google Scholar 

  21. Blumenfeld AM, Bloudek LM, Becker WJ, Buse DC, Varon SF, Maglinte GA, et al. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II). Headache. 2013;53(4):644–55.

    Article  PubMed  Google Scholar 

  22. Seng EK, Holroyd KA. Optimal use of acute headache medication: a qualitative examination of behaviors and barriers to their performance. Headache. 2013;53(9):1438–50. This qualitative study describes patient and provider perceptions about the medication-taking behaviors necessary for optimal use of acute headache medications, highlighting the barriers patients experience in their daily lives as they attempt to adhere with acute headache medication.

    PubMed  Google Scholar 

  23. Gaul C, van Doorn C, Webering N, Dlugaj M, Katsarava Z, Diener HC, et al. Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study. J Headache Pain. 2011;12(4):475–83.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Wu YP, Pai AL. Health care provider-delivered adherence promotion interventions: a meta-analysis. Pediatrics. 2014;133(6):e1698–707.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Haynes RB, Yao X, Degani A, Kripalani S, Garg A, McDonald HP. Interventions to enhance medication adherence. Cochrane Database Syst Rev. 2005;4, CD000011.

    PubMed  Google Scholar 

  26. Holroyd K, Cottrell C, O’Donnell F, Cordingley G, Carson B, Himiwan L. Effect of preventive (B blocker) treatment, behavioral migraine management or their combination on outcomes of optimized acute therapy in frequent migraine: randomized trial. BMJ. 2010;341:c4871.

  27. Rains J, Penzien D, Lipchik G. Behavioral facilitation of medical treatment for headache part II: theoretical models and behavioral strategies for improving adherence. Headache. 2006;46(9):1395–403.

    Article  PubMed  Google Scholar 

  28. Spierings EL, Miree LF. Non-compliance with follow-up and improvement after treatment at a headache center. Headache. 1993;33(4):205–9.

    Article  CAS  PubMed  Google Scholar 

  29. Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care. 2004;42(7):649–52.

    Article  PubMed  Google Scholar 

  30. Wells RE, Markowitz SY, Baron EP, Hentz JG, Kalidas K, Mathew PG, et al. Identifying the factors underlying discontinuation of triptans. Headache. 2014;54(2):278–89. This study describes correlates of triptan discontinuation, highlighting the roles of treatment efficacy, migraine-related disability, psychiatric symptoms and triptan-related beliefs.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Hahn S, Lipton R, Sheftell F. Healthcare provider-patient communication and migraine assessment: results of the American Migraine Communication Study (AMCS) phase II. Curr Med Res Opin. 2006;24:1711–8.

    Article  Google Scholar 

  32. Saper JR, Lake 3rd AE. Borderline personality disorder and the chronic headache patient: review and management recommendations. Headache. 2002;42(7):663–74.

    Article  PubMed  Google Scholar 

  33. Lash SJ, Stephens RS, Burden JL, Grambow SC, DeMarce JM, Jones ME, et al. Contracting, prompting, and reinforcing substance use disorder continuing care: a randomized clinical trial. Psychol Addict Behav J Soc Psychol Addict Behav. 2007;21(3):387–97.

    Article  Google Scholar 

  34. Bandura A. Self-efficacy: the exercise of control. New York: W.H. Freeman; 1997.

    Google Scholar 

  35. Seng EK, Holroyd KA. Dynamics of changes in self-efficacy and locus of control expectancies in the behavioral and drug treatment of severe migraine. Ann Behav Med. 2010;40(3):235–47.

    Article  PubMed  Google Scholar 

  36. Beck AT. Cognitive therapy and the emotional disorders. New York: International Universities Press; 1976.

    Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Elizabeth K. Seng is a consultant for Mercy Hospital Systems, received honoraria from Headache Cooperative of New England, and had travel/accommodations expenses covered or reimbursed by International Headache Academy (2014).

Jeanetta A. Rains reports National Institute of Health R21, Sleep Regulation and Circadian Phase in Chronic Migraine Position: Consultant. (Principal investigator: Jason Ong, PhD, Rush University) (2013–2015).

Robert A. Nicholson has no disclosures at this time.

Richard B. Lipton receives research support from the NIH: PO1 AG003949 (Program Director), PO1AG027734 (Project Leader), RO1AG025119 (Investigator), RO1AG022374-06A2 (Investigator), RO1AG034119 (Investigator), RO1AG12101 (Investigator), K23AG030857 (Mentor), K23NS05140901A1 (Mentor), and K23NS47256 (Mentor), the National Headache Foundation, and the Migraine Research Fund; serves on the editorial boards of Neurology and Cephalalgia and as senior advisor to Headache, has reviewed for the NIA and NINDS, holds stock options in eNeura Therapeutics (a company without commercial products); serves as consultant, advisory board member, or has received honoraria from: Alder, Allergan, American Headache Society, Autonomic Technologies, Avanir, Boston Scientific, Bristol Myers Squibb, Colucid, Dr. Reddy’s, Electrocore, Eli Lilly, Endo, eNeura Therapeutics, Informa, Labrys, Merck, Novartis, Teva, Vedanta.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elizabeth K. Seng.

Additional information

This article is part of the Topical Collection on Psychological and Behavioral Aspects of Headache and Pain

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seng, E.K., Rains, J.A., Nicholson, R.A. et al. Improving Medication Adherence in Migraine Treatment. Curr Pain Headache Rep 19, 24 (2015). https://doi.org/10.1007/s11916-015-0498-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11916-015-0498-8

Keywords

Navigation